Teladoc Health (NYSE: TDOC) is somewhat of a hybrid company, caught between technology and healthcare. The company is considered a software company, but it provides on-demand healthcare services—an interesting mix of attributes. Regardless of what the company does, the stock has been in a downward trend for the last seven months.
The decline started last October and it saw the stock drop from over $85 a share to $42.50 in December. The stock rallied back in January and February, but then turned lower again in March. If we connect the high closing prices from September and February we get a downward sloped trend line and the stock has rallied up to that line in recent weeks.
In addition to the trend line, we see that the stock is struggling to move back above its 50-day moving average. It moved above it on May 1, but it couldn’t maintain the momentum in to the close. We also see that the daily stochastic readings are in overbought territory and made a bearish crossover on May 1.
Teladoc’s fundamentals are below average, at least in terms of its earnings growth and management efficiency measurements. The company saw earnings decline by 10% in its fourth quarter report and earnings have been flat over the last three years. The company is set to report again on May 6.
Because the company has been losing money, the return on equity is currently -12.35% and the profit margin is -23.2%.
The Tickeron AI Prediction tool generated a bearish signal on Teladoc on April 30 and that signal calls for a decline of at least 4% over the next month. The signal showed a confidence level of 66% while previous predictions for the stock have been successful 64% of the time.
The 50-day moving average for TDOC moved above the 200-day moving average on June 25, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on June 16, 2026. You may want to consider a long position or call options on TDOC as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for TDOC just turned positive on June 17, 2026. Looking at past instances where TDOC's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TDOC advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 166 cases where TDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for TDOC moved out of overbought territory on July 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
TDOC broke above its upper Bollinger Band on July 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.225) is normal, around the industry mean (7.813). TDOC has a moderately low P/E Ratio (0.000) as compared to the industry average of (53.848). TDOC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.280). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (0.640) is also within normal values, averaging (6.086).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TDOC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TDOC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a telephone and online video consultation service
Industry ServicestotheHealthIndustry